No Data
No Data
Enveric Stock Climbs 7% on Deal for Radiation Dermatitis Drug
Aries Science Inks Licensing Deal For Enveric Biosciences' Radiation Dermatitis Topical Product
Express News | Aries Science & Technology And Enveric Biosciences Announce Licensing Agreement; Eligible To Receive Milestone Payments Of Up To $61M On Future Sales, If All Conditions Met
Express News | Enveric Biosciences-Co to Be Eligible to Receive Milestone Payments of up to $61 Mln on Future Sales, IF All Conditions Met
Express News | Enveric Biosciences Inc- Aries Science & Technology and Enveric Biosciences Announce Licensing Agreement
New Patented Psychedelic Drug Brings Hope For Brain Disorder Therapies
Enveric Biosciences (NASDAQ:ENVB), a biotechnology company specializing in neuroplastogenic therapeutics, has been granted a U.S. patent for its drug candidate EB-002. The license, No. 11,945,778,
No Data
Atom Boy’s Mommy : I don’t have any hopes on this stock, just wait for it to raise it back to 3 and sell
AmpOP Atom Boy’s Mommy: Take a look at the stocks listed in my post